Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc and certain officers for alleged violations of federal securities laws during the specified class period from February 27, 2025, to November 4, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Perrigo securities during the class period [2] - The Complaint alleges that Defendants made materially false and misleading statements and failed to disclose adverse facts about the Company's business and operations [3] - Specific allegations include significant underinvestment in the infant formula business acquired from Nestlé, the need for substantial capital expenditures, and manufacturing deficiencies [8] Group 2: Investor Participation - Investors who suffered losses in Perrigo have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Participation in any recovery does not require serving as lead plaintiff [3] Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only be reimbursed for expenses if successful [4] - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [5]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Perrigo Company plc during the specified Class Period, highlighting potential compensation opportunities for affected investors [2][3]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between February 27, 2023, and November 4, 2025, and a lead plaintiff must be appointed by January 16, 2026 [2][4]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Reasons for the Lawsuit - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from significant underinvestment and required substantial capital expenditures [6]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [5].